New search Hide text from Guidelines
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTSThis group comprises preparations used in the treatment of neoplastic diseases, and immunomodulating agents.
Corticosteroids for systemic use, see H02.
L03 IMMUNOSTIMULANTS
Immunosuppressants, see L04A.
L03A IMMUNOSTIMULANTS
Levamisole, which also affects the immune response, is classified in P02CE.
L03AC Interleukins
| The DDD for aldesleukin is based on the use of 5 vials (6.5 mg) per treatment cycle of 33 days. |
| ATC code | Name | DDD | U | Adm.R | Note |
| L03AC01 | aldesleukin | 0.2 | mg | P |
Last updated: 2024-01-26